title: Thulium laser enucleation of the prostate is a safe and a highly effective modality for the treatment of benign prostatic hyperplasia - Our experience of 236 patients.
abstract: BACKGROUND
  Thulium LASER is fast emerging as a safe and effective modality for benign prostatic hyperplasia (BPH). Still, compared to holmium laser transurethral enucleation of the prostate (HoLEP) the number of institutes all over the world using Thulium LASER are limited. This is our effort to bring the statistical facts about the safety and effectivity of Thulium LASER.
  
  
  OBJECTIVE
  To study the efficacy of thulium laser enucleation of the prostate (ThuLEP).
  
  
  METHODS
  All patients in the stipulated period were documented for all parameters and were evaluated. The results were tabulated.
  
  
  METHODS
  (1) Two hundred and thirty-six patients with symptomatic BPH were treated with ThuLEP between March 2010 and September 2014 at our institute by a single surgeon. (2) The inclusion criteria were maximum urinary flow rate (Qmax) <15 ml/s, International Prostate Symptoms Score (IPSS) >15 or acute retention of urine with the failure of catheter trial or Acute retention of urine with prior history of severe bladder outlet obstruction. (3) Patients evaluated by: Digital rectal examination, uroflowmetry, IPSS, prostate-specific antigen (PSA), blood and urine routine tests, abdominal usage with trains rectal ultrasonography (TRUS), TRUS guided biopsies.
  
  
  METHODS
  Not used.
  
  
  RESULTS
  (1) ThuLEP was a highly effective procedure as compared to all other procedures like HOLEP, TURP in terms of catheterization time, hospital stay, and drop in hemoglobin (Hb). (2) Catheterization time: 25.22 h (224 patients within 24 h and 12 patients within 48 h). (3) Hospital stay: 24-36 h 218 patients (92.3%), 36-48 h 18 patients (7.6%). (4) Drop in Hb: 0.8 ± 0.42 g/dl. (5) Average operative time: 56.91 min.
  
  
  CONCLUSIONS
  Thulium LASER is a safe and highly effective LASER in terms of blood loss, speed of tissue resection, drop in serum PSA, and versatility of prostatic resection.
authors.affiliation: Pramodini Urology Foundation, Pune, Maharashtra, India.
authors.forename: P Vartak
authors.initials: PV
authors.lastname: Ketan
authors.affiliation: Pramodini Urology Foundation, Pune, Maharashtra, India.
authors.forename: H Salvi
authors.initials: HS
authors.lastname: Prashant
keywords: Benign prostatic hyperplasia; enucleation; morbidity; morcellation; mortality; thulium laser
references.citation: BMC Surg. 2012;12 Suppl 1:S21
references.pmid: 23173611
references.citation: Zhonghua Nan Ke Xue. 2009 Apr;15(4):346-9
references.pmid: 19472910
references.citation: Eur Urol. 2009 Feb;55(2):368-75
references.pmid: 19022557
references.citation: BJU Int. 2013 Apr;111(4):633-7
references.pmid: 23107074
references.citation: J Urol. 2011 Nov;186(5):1972-6
references.pmid: 21944127
references.citation: Eur Urol. 2008 Feb;53(2):382-89
references.pmid: 17566639
references.citation: J Urol. 2008 Dec;180(6):2431-5; discussion 2435
references.pmid: 18930490
references.citation: Eur Urol. 2013 May;63(5):859-67
references.pmid: 23245687
references.citation: BJU Int. 2009 Aug;104(3):361-4
references.pmid: 19220261
references.citation: J Urol. 2010 Mar;183(3):1105-9
references.pmid: 20092844
references.citation: Urology. 2012 Apr;79(4):869-74
references.pmid: 22342411